Related references
Note: Only part of the references are listed.Inflammation in atherosclerosis - Visualizing matrix metalloproteinase action in macrophages in vivo
Jun-o Deguchi et al.
CIRCULATION (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Attenuation of skeletal muscle atrophy via protease inhibition
CA Morris et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1
YW Chen et al.
CARCINOGENESIS (2005)
Selective radioprotection of normal tissues by Bowman-Birk proteinase inhibitor (BBI) in mice
K Dittman et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2005)
Cancer prevention: A global perspective
BW Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of plant protease inhibitors, oryzacystatin I and soybean Bowman-Birk inhibitor, on the aphid Macrosiphum euphorbiae (Homoptera, Aphididae) and its parasitoid Aphelinus abdominalis (Hymenoptera, Aphelinidae)
H Azzouz et al.
JOURNAL OF INSECT PHYSIOLOGY (2005)
Biorational approaches for insect control by enzymatic inhibition
A Guerrero et al.
CURRENT MEDICINAL CHEMISTRY (2005)
In vitro inhibition of the activation of pro-matrix metalloproteinase 1 (Pro-MMP-1) and pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors
HA Bawadi et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Antiproliferative crude soy saponin extract modulates the expression of IκBα, protein kinase C, and cyclooxygenase-2 in human colon cancer cells
HY Kim et al.
CANCER LETTERS (2004)
Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman-Birk inhibitor
JN Losso et al.
BIOTECHNOLOGY LETTERS (2004)
Inhibitory effect of topical applications of nondenatured soymilk on the formation and growth of UVB-induced skin tumors
MT Huang et al.
ONCOLOGY RESEARCH (2004)
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease
JC Adair et al.
STROKE (2004)
Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment
WB Armstrong et al.
LARYNGOSCOPE (2003)
Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice
AR Kennedy et al.
PHARMACEUTICAL RESEARCH (2003)
Effect of membranotropic and mucoadhesive formulations of protein proteinase inhibitors on bovine herpes virus-1 reproduction
NV Larionova et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Toxicity to the pea aphid Acyrthosiphon pisum of anti-chymotrypsin isoforms and fragments of Bowman-Birk protease inhibitors from pea seeds
Y Rahbé et al.
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Selection by phage display of a variant mustard trypsin inhibitor toxic against aphids
LR Ceci et al.
PLANT JOURNAL (2003)
Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor
EV Malykh et al.
BIOCHEMISTRY-MOSCOW (2002)
Plant toxic proteins with insecticidal properties.: A review on their potentialities as bioinsecticides
CR Carlini et al.
TOXICON (2002)
MMPs and TIMPs - An historical perspective
JF Woessner
MOLECULAR BIOTECHNOLOGY (2002)
Chemical synthesis and kinetic study of the smallest naturally occurring trypsin inhibitor SFTI-1 isolated from sunflower seeds and its analogues
E Zablotna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Study on interaction between duodenase-protease with dual specificity and inhibitors of Bowman-Birk family
IP Gladysheva et al.
PROTEIN AND PEPTIDE LETTERS (2002)
Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells
AR Kennedy et al.
PROSTATE (2002)
Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate
XS Wan et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2002)
A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans
XY Ye et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells
XY Sun et al.
CARCINOGENESIS (2001)
The macrobiotic diet in cancer
LH Kushi et al.
JOURNAL OF NUTRITION (2001)
Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor
IP Gladysheva et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Synthetic peptide mimics of the Bowman-Birk inhibitor protein
JD McBride et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Bowman-Birk proteinase inhibitor-mediated radioprotection against UV irradiation is TP53-dependent and associated with stimulation of nucleotide excision repair
K Dittmann et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2001)
Other novel agents: Rationale and current status as chemopreventive agents
AW Tolcher et al.
UROLOGY (2001)
Acylation of Bowman-Birk soybean proteinase inhibitor by unsaturated fatty acid derivatives
EV Malykh et al.
BIOCHEMISTRY-MOSCOW (2001)
Anti-cariogenic properties of tea (Camellia sinensis)
JMT Hamilton-Miller
JOURNAL OF MEDICAL MICROBIOLOGY (2001)
Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands
XT Du et al.
CANCER LETTERS (2001)
X-ray study on an artificial mung bean inhibitor complex with bovine β-trypsin in neat cyclohexane
GY Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Role of cadherins and matrixins in melanoma
C Gruss et al.
CURRENT OPINION IN ONCOLOGY (2001)
Nutritional and health benefits of soy proteins
M Friedman et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties?
VM Dirsch et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Excessive matrix metalloproteinase activity in diabetes: Inhibition by tetracycline analogues with zinc reactivity
ME Ryan et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Characterization of a rice (Oryza sativa L.) Bowman-Birk proteinase inhibitor:: tightly light regulated induction in response to cut, jasmonic acid, ethylene and protein phosphatase 2A inhibitors
R Rakwal et al.
GENE (2001)
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer
E Hrabec et al.
RESPIRATORY MEDICINE (2001)
Role of gap-junctional communication in breast cancer progression and chemoprevention
MJ Sawey
JOURNAL OF NUTRITION (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging
EA Baker et al.
BRITISH JOURNAL OF SURGERY (2000)
Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 Å resolution.: Structural basis of Janus-faced serine protease inhibitor specificity
J Koepke et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Chymase is a potent chemoattractant for human monocytes and neutrophils
K Tani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Clinical potential of matrix metalloprotease inhibitors in cancer therapy
EI Heath et al.
DRUGS (2000)
Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents
GJ Kelloff et al.
JOURNAL OF NUTRITION (2000)
Share Paper
